Archive: CIPO2015: Adoptive T Cell Immunotherapy Targeting the Minor Histocompatibility Antigen HA-1

630 views · Published 15 October 2015 · 15:02 · Indexed 18 October 2026

Channel: UW Video · 2015 · Education

Watch on YouTube

Dr. Robson Dossa of Fred Hutchinson Cancer Research Center speaks about adoptive cell therapies for pediatric cancers at the 4th International Conference on Immunotherapy in Pediatric Oncology (CIPO2015), hosted by Seattle Children’s Research Institute.

Dr. Dossa’s talk focuses on the development of an adoptive T cell immunotherapy employing genetically modified T cells against the minor H antigens, and provides detail about the hematopoietic-restricted, leukemia-associated minor histocompatibility antigen HA-1.

Robson Dossa, PhD, Postdoctoral Research Fellow, Fred Hutchinson Cancer Research Center

09/26/2015

http://www.seattlechildrens.org/research/

http://www.seattlechildrens.org/research/childhood-cancer/CIPO-2015/

https://uw.edu/video
The University of Washington is committed to ensuring digital accessibility in our services, programs, and activities. If you encounter accessibility barriers using videos found on this channel, please contact UW Video at uwvideo [at] uw [dot] edu.

More from this channel